Finding 586551 (2021-003)

Material Weakness
Requirement
ABL
Questioned Costs
-
Year
2021
Accepted
2024-01-25

AI Summary

  • Core Issue: The Organization lacked a proper internal control process for reviewing and approving claims related to the COVID-19 Provider Relief Fund.
  • Impacted Requirements: Compliance with 2 CFR 200.303(a) was not met, risking the accuracy of claimed expenditures and lost revenue calculations.
  • Recommended Follow-Up: Implement a secondary review and approval process for all expenditure listings and reports submitted to ensure compliance and accuracy.

Finding Text

2021-003 Department of Health and Human Services CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year – Period 1 TIN #381649577 Activities Allowed or Unallowed, Allowable Costs/Cost Principles, and Reporting Material Weakness in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The Organization claimed expenses based on specifically identified COVID related expenses and general and administrative expenses. Condition: The Organization’s final expenditure listing identified as eligible and claimed under the Provider Relief Fund program as well as the prepared lost revenue calculation were not reviewed and approved by a separate individual outside of the preparer. Cause: The Organization did not have an internal control process in place to ensure a secondary review and approval of the lost revenue calculation or of eligible expenditures that were summarized from the underlying supporting spreadsheets to the final expenditure listing was formally documented. The summary spreadsheet was used to claim allowable costs under the federal program. In addition, the review and approval of the report submitted to the Department of Health and Human Services for Period 1 was not performed by someone other than the preparer of the report. Effect: Without a secondary review and approval, there is a possibility that ineligible expenditures or lost revenue may have been claimed under the program and the report may not have been accurately completed. Questioned Costs: None reported. Context/Sampling: A nonstatistical sample of 65 ($92,432) out of 993 expenditures ($1,198,401) was tested for activities allowed or unallowed and allowable costs/cost principles. Lost revenue was reviewed as submitted in the special report. Additional key line items were tested on the Period 1 Department of Health and Human Services special report submitted. Repeat Finding from Prior Years: No Recommendation: We recommend the Organization implement a control process which includes a secondary review and approval of the summarized final expenditure listing and lost revenue calculation used to claim the allowable costs under the federal program and a secondary review and approval of required reports to be submitted to the federal agency. Views of Responsible Officials: Management agrees with the finding.

Categories

Allowable Costs / Cost Principles Eligibility Material Weakness Reporting

Other Findings in this Audit

  • 10109 2021-003
    Material Weakness
  • 10110 2021-004
    Material Weakness
  • 10111 2021-005
    Material Weakness
  • 586552 2021-004
    Material Weakness
  • 586553 2021-005
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.498 Covid-19 Provider Relief Fund $4.41M
93.697 Covid-19 Testing for Rural Health Clinics $433,942
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $77,349
93.301 Small Rural Hospital Improvement Grant Program $67,500
93.889 National Bioterrorism Hospital Preparedness Program $7,000